FDA OKs Abbott diabetes device
- Share via
Abbott Laboratories won U.S. approval of a glucose-monitoring system for people with diabetes that provides minute-by-minute and trend information to help patients manage the disease.
The system, called the FreeStyle Navigator, measures blood sugar through a sensor in the back of the upper arm or through the abdomen.
The information can help manage treatment, although traditional blood tests must be performed before therapy can be adjusted, the company said.
From Times Wire Services
More From the Los Angeles Times
Podcasts
The latest effort is coming from the L.A. County Board of Supervisors. They just announced a $3 million program in conjunction with some nonprofits groups to test and clean the soil at homes still standing in the areas impacted by the Eaton Fire.
California once bet big on offshore wind to help power its clean-energy future, but the Trump administration is now paying developers billions to walk away from their projects. As California’s remaining offshore-wind leases hang in the balance, the state is fighting back in court.
The Hillside Strangler murders terrorized Los Angeles in the late 1970s. The killers were a pair of sadistic cousins. One confessed. The other was set to stand trial—until L.A. prosecutors flinched.
